BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21296417)

  • 1. Neuromedin U(2) receptor signaling mediates alteration of sleep-wake architecture in rats.
    Ahnaou A; Drinkenburg WH
    Neuropeptides; 2011 Apr; 45(2):165-74. PubMed ID: 21296417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
    Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
    Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal REM sleep is regulated by corticotropin releasing factor.
    Feng P; Liu X; Vurbic D; Fan H; Wang S
    Behav Brain Res; 2007 Aug; 182(1):95-102. PubMed ID: 17588683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion of the pedunculopontine tegmental nucleus in rat augments cortical activation and disturbs sleep/wake state transitions structure.
    Petrovic J; Ciric J; Lazic K; Kalauzi A; Saponjic J
    Exp Neurol; 2013 Sep; 247():562-71. PubMed ID: 23481548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
    Ahnaou A; Steckler T; Heylen A; Kennis L; Nakazato A; Chaki S; Drinkenburg WH
    Eur J Pharmacol; 2012 Apr; 680(1-3):63-8. PubMed ID: 22314225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fluoromethylhistidine, a histamine synthesis inhibitor, inhibits orexin-induced wakefulness in rats.
    Yasuko S; Atanda AM; Masato M; Kazuhiko Y; Kazuki H
    Behav Brain Res; 2010 Feb; 207(1):151-4. PubMed ID: 19818811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain orexins and wake regulation in rats exposed to maternal deprivation.
    Feng P; Vurbic D; Wu Z; Strohl KP
    Brain Res; 2007 Jun; 1154():163-72. PubMed ID: 17466285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-chronic administration of zolpidem affects modifications to rat sleep architecture.
    Renger JJ; Dunn SL; Motzel SL; Johnson C; Koblan KS
    Brain Res; 2004 Jun; 1010(1-2):45-54. PubMed ID: 15126116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased non-rapid eye movement sleep by cocaine withdrawal: possible involvement of A2A receptors.
    Yang SL; Han JY; Kim YB; Nam SY; Song S; Hong JT; Oh KW
    Arch Pharm Res; 2011 Feb; 34(2):281-7. PubMed ID: 21380812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurochemical mechanisms of sleep regulation].
    Glas Srp Akad Nauka Med; 2009; (50):97-109. PubMed ID: 20666118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep-wake cycle in the freely moving rats.
    Datta S; Siwek DF
    J Neurosci Res; 2002 Nov; 70(4):611-21. PubMed ID: 12404515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
    Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
    Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
    Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
    J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat.
    Ulloor J; Mavanji V; Saha S; Siwek DF; Datta S
    J Neurophysiol; 2004 Apr; 91(4):1822-31. PubMed ID: 14702336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromedin U-induced anorexigenic action is mediated by the corticotropin-releasing hormone receptor-signaling pathway in goldfish.
    Maruyama K; Wada K; Ishiguro K; Shimakura S; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
    Peptides; 2009 Dec; 30(12):2483-6. PubMed ID: 19699772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide-S evoked arousal with electroencephalogram slow-wave compensatory drive in rats.
    Ahnaou A; Drinkenburg WH
    Neuropsychobiology; 2012 Jun; 65(4):195-205. PubMed ID: 22538299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system.
    Mondal MS; Date Y; Murakami N; Toshinai K; Shimbara T; Kangawa K; Nakazato M
    Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G963-9. PubMed ID: 12584108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chloramphenicol on brain energy metabolism using 31P spectroscopy: influences on sleep-wake states in rat.
    Chahboune H; Mahdjoub R; Desgoutte P; Rousset C; Briguet A; Cespuglio R
    J Neurochem; 2008 Aug; 106(4):1552-62. PubMed ID: 18507739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromedin U enhances proliferation of ACTH-stimulated adrenocortical cells in the rat.
    Trejter M; Guidolin D; Nowak M; Macchi V; Majchrzak M; De Caro R; Malendowicz LK
    Int J Mol Med; 2009 Jan; 23(1):99-104. PubMed ID: 19082512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.